Health Catalyst, Inc. (HCAT)

Health Catalyst's stock price has experienced significant volatility over the past six months. Key events impacting the stock include the Q3 2025 earnings report, which exceeded guidance, and the Q4 and year-end 2025 operating results, which led to a stock plunge due to missed earnings estimates and a lack of annual guidance. Analyst downgrades and price target cuts also occurred in March 2026. The Q1 2026 earnings report is scheduled for May 11, 2026, with analysts expecting a year-on-year revenue decline.

Explicit information regarding the demand seasonality for Health Catalyst's products and services is not directly available. Demand may be relatively stable throughout the year due to the nature of healthcare data analytics and improvement services.

Health Catalyst, Inc. is a leading provider of data and analytics technology and services to healthcare organizations, operating in the Health Care Technology sector. Its core offering is the cloud-based data platform, Health Catalyst Ignite™, which integrates various data sources into a unified analytics environment. The company operates through two segments: Technology, which includes the data platform and analytics applications, and Professional Services, which provides analytics, implementation, and advisory services.

Health Catalyst, Inc. is headquartered in South Jordan, Utah, and serves more than 450 healthcare organizations across the U.S., with over 1,100 organizations worldwide relying on its offerings.

Health Catalyst has received positive recognition for its workplace culture and contributions to healthcare innovation. The company was recognized as a 'Best Place to Work' and included in Gallup's 40 Global Great Workplaces. Health Catalyst announced the winners of its 2025 Catalyst Awards, recognizing healthcare organizations for their data-driven transformation efforts. The company has also expanded strategically, including the acquisition of cybersecurity provider Intraprise Health.

The ownership structure of Health Catalyst stock is a mix of institutional, retail, and individual investors. Institutional investors own approximately 58.27% to 68.99% of the company's stock. Insiders own approximately 7.72% of the company's stock. Public companies and individual investors hold between 10.72% and 23.29% of the stock.